1 / 17

MCIC VTE Prophylaxis All Team Call

MCIC VTE Prophylaxis All Team Call. Sean Berenholtz, MD MHS and VTE Subcommittee 5.23.2006. MCIC VTE Subcommittee. Safety Measures. How often do we harm patients? Measures of harm (Surgical site infections (SSI)) How often do we do what we should?

stew
Download Presentation

MCIC VTE Prophylaxis All Team Call

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MCIC VTE Prophylaxis All Team Call Sean Berenholtz, MD MHS and VTE Subcommittee 5.23.2006

  2. MCIC VTE Subcommittee

  3. Safety Measures • How often do we harm patients? • Measures of harm (Surgical site infections (SSI)) • How often do we do what we should? • Surgical Care Improvement Project (SCIP) process measures, • Venous thromboembolism (VTE) prophylaxis, • How often do we learn from defects? • Learn from one per month (National Quality Forum never events, mislabeled specimens) • How well do we improve culture? • Safety Attitude Questionnaire (SAQ), • Comprehensive Unit Safety Program (CUSP)

  4. Most common preventable cause of hospital death Annual Incidence in US Hirsh DR et al. JAMA 1995;274:335-7 Bick RL Semin Thromb Hemost 1999;25:251-3

  5. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep;126(3 Suppl):338S-400S

  6. Recommendations • General surgery • surgical oncology, gynecology, urology, vascular, transplant, thoracic surgery • Orthopedics • Trauma • Neurosurgery

  7. Overall Adherence for VTE Prophylaxis at JHHS: Baseline n = 71/219* n = 7/8 n = 3/13 n = 20/88 n = 13/44 n = 1/4 n = 12/16 n = 12/31 n = 3/15 * Aggregate DOES NOT INCLUDE GU cases that were contraindicated for pharmacologic interventions

  8. SCIP Measures • SCIP VTE 1: Surgery patients with recommended VTE prophylaxis ordered • SCIP VTE 2: Surgery patients who received appropriate VTE prophylaxis within 24 hours prior to surgery to 24 hours after surgery • SCIP VTE 3: Intra- or postoperative PE diagnosed during index hospitalization and within 30 days of surgery (OUTCOME) • SCIP VTE 4: Intra- or postoperative DVT diagnosed during index hospitalization and within 30 days of surgery (OUTCOME)

  9. Assumptions • Data collected in immediate periop period (preop holding area thru time of PACU/ICU admission • Concurrent data collection preferred • Risk stratification defined by local consensus • Evidence of risk stratification includes a completed risk stratification tool, a physician, NP, or PA note documenting that the patient is at risk for VTE • Exclusions: < 18 yo, hospital LOS < 24 hours

  10. Proposed MCIC VTE Measures • General surgery (includes surg onc, urology, vascular and transplant surgery) • Trauma • Neurosurgery (intracranial, spinal cord injury, elective spine surgery) • Bariatric surgery

  11. Proposed MCIC VTE Measures • Documentation of Risk Stratification • % patients with evidence of risk stratification in chart • Prophylaxis for VTE • % patients who have an order written to start prophylaxis during the time period within 24 hrs prior to incision through 24 hrs after surgery end time • % patients who have an order written to start prophylaxis at the recommended dosing during the time period within 24 hrs prior to incision time through 24 hrs after surgery end time

  12. Proposed MCIC VTE Measures • Contraindications to VTE prophylaxis • % patients with any contraindication to pharmacologic prophylaxis • % patients with contraindication to pharmacologic prophylaxis due to a high risk of bleeding treated with mechanical prophylaxis (GCS or IPC or SCD) • % patients included in review process GCS: graduated compression stockings; IPC: intermittent pneumatic compression devices; SCD: sequential compression devices

  13. Data Collection Plan • Data collection tool developed • Pilot testing: June 2006 • Concurrent data collection: convenience sample of 5-10 pts • Retrospective Review: 10 randomly selected patient-charts • Implementation: July 2006 • Concurrent data collection: All patients seen by the clinical area improvement team • Retrospective Review: 10 randomly selected patient-charts per month per surgery type • Maintenance: >= 90% performance • TBD

  14. Reports • Single period reports • Performance over time • Comparison to collaborative • Data remains anonymous

  15. Change is Local • Educate staff • Partner with hematology, Guidelines, Fact sheet, powerpoint slides • Reduce complexity • Standardized tool, computerized decision support • Create redundancy • Multidisciplinary teams, add to existing checklists, briefings/debriefings • Measure performance • Identify when this will occur during the periop period

  16. Team Check-up Tool • Reviewed data with team • Number of team meetings • Met with executive • Reviewed data with executive • Barriers to progress

  17. Next Steps • Finalize teams • Gain consensus on evidence and risk stratification • Pilot test data collection tool • Conference call to review pilot phase • Burden, revise measures/tools, timeline • Live the grid • Conference calls for sharing

More Related